Your browser doesn't support javascript.
loading
Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers.
Sartor, Oliver; Ledet, Elisa; Huang, Minqui; Schwartz, Jennifer; Lieberman, Alex; Lewis, Brian; Layton, Jodi; Barata, Pedro; Jang, Albert; Hawkins, Madeline; Pocha, Olivia; Lanka, Sree; Harris, Kendra.
Afiliação
  • Sartor O; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana; sartor.oliver@mayo.edu.
  • Ledet E; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota; and.
  • Huang M; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana.
  • Schwartz J; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana.
  • Lieberman A; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana.
  • Lewis B; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana.
  • Layton J; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana.
  • Barata P; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana.
  • Jang A; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana.
  • Hawkins M; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana.
  • Pocha O; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana.
  • Lanka S; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana.
  • Harris K; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, Louisiana.
J Nucl Med ; 64(11): 1721-1725, 2023 11.
Article em En | MEDLINE | ID: mdl-37770113

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / DNA Tumoral Circulante Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / DNA Tumoral Circulante Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article